首页> 外文期刊>中国癌症研究(英文版) >EFFECT ON BIOLOGICAL BEHAVIOR OF CHEMOTHERAPY-RESISTANT TUMOR CELLS BY HUMAN WILD-TYPE P53, GM-CSF AND B7-1 GENES VIA RECOMBINANT ADENOVIRUS
【24h】

EFFECT ON BIOLOGICAL BEHAVIOR OF CHEMOTHERAPY-RESISTANT TUMOR CELLS BY HUMAN WILD-TYPE P53, GM-CSF AND B7-1 GENES VIA RECOMBINANT ADENOVIRUS

机译:重组腺病毒对人野生型P53,GM-CSF和B7-1基因抗化学疗法对肿瘤细胞生物学行为的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To explore the effect on biological behavior of chemotherapy-resistant tumor cells by human wild-type p53, GM-CSF and B7-1 genes mediated via recombinant adenovirus. Methods: p53-abnormal KB-v200 (VCR resistant) and KB-s (VCR sensitive) cell lines were used as model tumor cells, which are resistant and sensitive to chemotherapeutic drugs respectively. After infected with recombinant adenovirus carrying human wild-type p53, GM-CSF and B7-1 genes, changes in biological behavior (including drug sensitivity) of these two kinds of gene-transduced cancer cells were observed. Results: Both of the cell lines were susceptible to adenovirus, all of three exogenous genes (p53, GM-CSF and B7-1) could be effectively expressed in these cell lines, their growth was suppressed, and apoptosis was induced. The drug-pumping-out function of Pgp glycoprotein on the cytomembrane of drug-resistant KB-v200 cells was markedly affected 48h after transfection of the recombinant adenovirus, revealed by increase of the amount of rhodamine 123 accumulation in the cells. The MTT assay also indicated the reversal of their sensitivity to VCR drugs. In vivo experiment in nude mice it was demonstrated reduction of tumorigenicity of the KB-v200 cells or KB-s cells infected with the recombinant adenovirus, and increase of their sensitivity to VCR. Conclusion: The clinical application of this recombinant adenovirus carrying agents might be more effective in treatment of tumors with multidrug resistance (MDR).
机译:目的:探讨通过重组腺病毒介导的人野生型P53,GM-CSF和B7-1基因对化疗抗性肿瘤细胞生物学行为的影响。方法:P53-异常KB-V200(VCR抗性)和KB-S(VCR敏感)细胞系用作模型肿瘤细胞,其分别对化学治疗药物耐药和敏感。在感染携带人野生型P53,GM-CSF和B7-1基因的重组腺病毒后,观察到这两种基因转导癌细胞的生物行为(包括药物敏感性)的变化。结果:两种细胞系易患腺病毒,所有三种外源基因(P53,GM-CSF和B7-1)可以在这些细胞系中有效地表达,其生长抑制,诱导细胞凋亡。在重组腺病毒转染后,PGP糖蛋白在耐药性KB-V200细胞的细胞膜上的药物泵送功能明显影响48h,揭示了细胞中罗丹明123积累量的增加。 MTT测定还表明它们对VCR药物的敏感性的逆转。在裸鼠体内实验中,据证明了kB-V200细胞或KB-S细胞的致瘤性降低,感染重组腺病毒,以及对VCR的敏感性的增加。结论:该重组腺病毒携带剂的临床应用可能更有效地治疗多药耐药性(MDR)。

著录项

  • 来源
    《中国癌症研究(英文版)》 |2000年第2期|105-114|共10页
  • 作者

  • 作者单位

    Beijing Institute of Radiation Medicine , Beijing 100850, China;

    Beijing Institute of Radiation Medicine , Beijing 100850, China;

    Beijing Institute of Radiation Medicine , Beijing 100850, China;

    Beijing Institute of Radiation Medicine , Beijing 100850, China;

    Beijing Institute of Radiation Medicine , Beijing 100850, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    Tumor gene therapy; multidrug resistance; adenoviral vector;

    机译:肿瘤基因治疗;多药耐药;腺病毒载体;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号